HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guowei Deng Selected Research

porphycene

1/2021A red-light-activated sulfonamide porphycene for highly efficient photodynamic therapy against hypoxic tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guowei Deng Research Topics

Disease

4Neoplasms (Cancer)
06/2022 - 03/2020
1Phototoxic Dermatitis (Phototoxicity)
06/2022
1Neoplasm Metastasis (Metastasis)
08/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Breast Neoplasms (Breast Cancer)
03/2020

Drug/Important Bio-Agent (IBA)

21-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2022 - 01/2021
1OxidesIBA
06/2022
1Nanoparticle Drug Delivery SystemIBA
08/2021
1Biological ProductsIBA
08/2021
1Pharmaceutical PreparationsIBA
08/2021
1EnzymesIBA
08/2021
1Peptide Hydrolases (Proteases)FDA Link
08/2021
1hydroxide ionIBA
01/2021
1SulfonamidesIBA
01/2021
1porphyceneIBA
01/2021
1Bovine Serum AlbuminIBA
03/2020
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
03/2020
1AlbuminsIBA
03/2020

Therapy/Procedure

2Photochemotherapy (Photodynamic Therapy)
06/2022 - 01/2021
1Precision Medicine
08/2021
1Lasers (Laser)
03/2020
1Photothermal Therapy
03/2020